Replies to post #40473 on Raadr Inc (RDAR)

[Chiron]

Look, you have to be realistic here. How on Earth can this uplist? It can't even get over .001 anymore.  

[CR500]

Telvantis, not Telvatis. 😊

[Bubae]

You might want to take more care about what you post. I for one would very much like to see a screen shot of that correspondence. Any of you other so called "Telvatis Ambassador's" want to maybe serve that up for me? It would be greatly appreciated. The company communicates one thing to the market then states something else to the coveted bag holders? 🤔 Yesterdays trading action must have not been what they expected and now are trying some back door damage control after losses realized by those dumping.? I for one would like to get an SEC opinion on that tactic as well as others deployed by this company's new Italian management since October. There have been tremendous losses banked here off of what has been shown to be a false narrative. Links in Post# 39362 to Mexedia's first half 2024 financials. This report wasn't released until October 29th, four months after the period end date.

So, if true, what that correspondence is saying is that yesterdays press release was intended to be a piece of promotional propaganda that famously backfired? So now, in my opinion, it is "incumbent on the company to immediately state" was is reported as being communicated in private. That is "No Reverse Split planned" and "Uplisting to NASDAQ is far out in the plans". Look up the word "Culpability".

Yesterdays press release was another effort to deceive in my opinion and it backfired this time because we all know the true state of Mexedia at this point. This deal gives Mexedia access to the U.S. capital market starting with this OTC listed company takeover. Those two Mexedia subsidiaries, representing 91% of their revenue, was rolled into the new holding company Telvantis. Those two entities became cash flow negative in a dramatic fashion for the first half of 2024 over that of 2023. This is why they still were promoting those 2023 financials at the micro-cap conference.

No Reverse Split planned, was the words written last night by Telvatis.

This came to the Telvatis Ambassador Group as a notice


Also Uplisting to NASDAQ is far out in the plans

Raadr (Doing Business as Telvantis) Positions for National Exchange Uplisting With Strategic Engagement of PCAOB Audit Firm HTL International, LLC
Feb. 6, 2025 8:00 AM ET Source: Telvantis Inc.
https://www.newmediawire.com/news/raadr-doing-business-as-telvantis-positions-for-national-exchange-uplisting-with-strategic-engagement-of-pcaob-audit-firm-htl-international-llc-7079273

...("Telvantis" or the "Company"), a rapidly expanding U.S.-based global telecommunications provider, today announced a significant step towards uplisting to a national exchange, such as the Nasdaq or NYSE, by engaging HTL International, LLC (HTL), a PCAOB-registered, full-service accounting firm.

....including expertise in guiding companies through the uplisting process. Companies that successfully complete a PCAOB audit and meet other listing requirements see an average increase in institutional investment of approximately 20% post-uplisting...

...said Daniel Gilcher, CFO of the Company. "Their expertise will be invaluable as we prepare for an uplisting to a national exchange and continue to execute our strategic growth plan...


Bubae
Re: just Scottie post# 39345
Friday, January 17, 2025 9:11:02 AM
Post# 39362 of 40475
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175678987&txt2find=owner%2Borlando

You might want to pay more attention to the the statement in that press release by the owner of Mexedia, Orlando Taddeo, the author of that shareholder letter. This person is boasting about Mexedia's 2023 financials knowing that 2024 numbers have fallen off a cliff. This merger agreement turned Raadr, now Telvantis, into a simple holding company of which Mexedia owns 75% of through the series F preferred shares handed over for nothing in the merger agreement. It doesn't work however unless they can con OTC retail into buying the regulation A offering shares. How do they make the $4.5 million priced at $0.003 offering viable? Amended price maybe, reverse split? We share see. One thing is for certain, they are desperate to get those shares sold. Watch for more misinformation to come in both the press releases and this board.

Screenshot of the statement of cash flows for the parent company Mexedia S.p.A below. €124K cash flow positive for the first half of 2023 to €534K cash flow negative the first half of 2024. That is a €658K swing to the negative. YOY Revenue for the first half of 2024 was down 71%. Net profit down 434%, EBITDA negative. The parent company, Mexedia, 52 week stock performance is down 75%.

[crowin]

Also Uplisting to NASDAQ is far out in the plans

Way out probable in 2036 after 2 reverse stock spits on the way

[BigBadWolf]

Since one's (comparison & condescending) smart ass reply. So, w/ that said I for once will break one of my own rules reaffirmation should also have been released publicly by the company.

After consulting w/ in general, it is illegal for a publicly traded company, including those on the OTC (over-the-counter) markets, to provide material non-public information (MNPI) to a select group of individuals, including a "Shareholder Ambassador" group, without making it available to the public. This would typically violate insider trading rules.

Key considerations:
Material Non-Public Information (MNPI):
This refers to any information that could impact an investor’s decision to buy or sell securities and is not yet made available to the broader public. Examples include financial results, mergers and acquisitions, or other corporate developments.
The SEC (Securities and Exchange Commission) has strict rules about the handling and dissemination of MNPI.
Insider Trading Laws:
The insider trading laws prohibit anyone with access to MNPI from trading on that information or sharing it with others who might trade on it.
If a publicly traded company shares information that has not been made publicly available to a select group of people, this could be considered tipping or providing an unfair advantage, and it would be subject to penalties.
Regulation FD (Fair Disclosure):
Regulation FD (Regulation Fair Disclosure) was created to ensure that companies do not selectively disclose material information to certain individuals or groups before making it publicly available.
Under Regulation FD, if a company discloses material information to certain people (like analysts, institutional investors, or, in this case, a Shareholder Ambassador group), that information must also be made public simultaneously or soon after.
Consequences for Violations:
Violating these laws can result in severe penalties for the company and individuals involved, including fines, civil penalties, and criminal charges.
So, if the "Shareholder Ambassador" group is being given non-public, material information, it could violate SEC rules and other insider trading laws. Publicly traded companies must ensure equal access to important information to avoid legal and regulatory risks.

The Good The Bad The Ugly